Pei Jun-Peng, Zhang Chun-Dong, Liang Yu, Zhang Cheng, Wu Kun-Zhe, Li Yong-Zhi, Zhao Zhe-Ming, Dai Dong-Qiu
Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Front Oncol. 2020 Nov 11;10:548692. doi: 10.3389/fonc.2020.548692. eCollection 2020.
The American Joint Committee on Cancer 8th classification states that colorectal cancer (CRC) is classified as N1c stage when regional lymph nodes (LNs) are negative and tumor deposits (TDs) are positive. However, how to classify TDs when regional LNs are positive remains unclear. The current study aimed to investigate the possibility of combining positive LNs and positive TDs to develop a modified pathological N (mpN) stage for CRC.
We retrospectively analyzed 9,198 patients with stage III CRC from the Surveillance, Epidemiology, and End Results program who underwent surgery (6,440 in the training cohort and 2,758 the validation cohort). The combination of positive LNs and TD status was defined as mpN stage. Overall survival (OS) according to mpN and pathological N (pN) stages was analyzed by the Kaplan-Meier method. The area under the curves (AUCs) and Akaike's information criterion (AIC) were applied to assess the predictive discrimination abilities and goodness-of-fit of the model. The clinical benefits were measured using decision curve analyses. The validation cohort was used to validate the results.
AUC analysis showed that the prognostic discrimination of mpN stage (AUC = 0.628, 95% confidence interval (CI), 0.616-0.640) was better than that of pN stage (AUC = 0.618, 95% CI, 0.606-0.630, p = 0.006) for OS. The AIC demonstrated that mpN stage (AIC = 30,217) also showed superior model-fitting compared with pN stage (AIC = 30,257) and decision curve analyses revealed that mpN stage had better clinical benefits than pN stage. Similar results were found in the validation cohort.
Among patients with CRC and LN metastasis, mpN stage might be superior to pN stage for assessing prognosis and survival, suggesting that TD status should be included in the pN stage.
美国癌症联合委员会第8版分类指出,当区域淋巴结(LN)为阴性而肿瘤结节(TD)为阳性时,结直肠癌(CRC)被分类为N1c期。然而,当区域LN为阳性时如何对TD进行分类仍不清楚。当前研究旨在探讨将阳性LN和阳性TD相结合以制定CRC改良病理N(mpN)分期的可能性。
我们回顾性分析了监测、流行病学和最终结果计划中9198例接受手术的III期CRC患者(训练队列6440例,验证队列2758例)。将阳性LN与TD状态的组合定义为mpN分期。采用Kaplan-Meier法分析根据mpN和病理N(pN)分期的总生存期(OS)。应用曲线下面积(AUC)和赤池信息准则(AIC)评估模型的预测辨别能力和拟合优度。使用决策曲线分析衡量临床获益。验证队列用于验证结果。
AUC分析显示,对于OS,mpN分期(AUC = 0.628,95%置信区间(CI),0.616 - 0.640)的预后辨别能力优于pN分期(AUC = 0.618,95% CI,0.606 - 0.630,p = 0.006)。AIC表明,mpN分期(AIC = 30217)与pN分期(AIC = 30257)相比也显示出更好的模型拟合,决策曲线分析显示mpN分期比pN分期具有更好的临床获益。在验证队列中发现了类似结果。
在伴有LN转移的CRC患者中,mpN分期在评估预后和生存方面可能优于pN分期,这表明pN分期应纳入TD状态。